Acumen Pharmaceuticals Inc
(ABOS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -6,570 | -4,080 | -2,045 | -7,907 |
| Accounts payable and accrued liabilities | 1,231 | 380 | 153 | N/A |
| Other Working Capital | 1,861 | 693 | 190 | 768 |
| Other Operating Activity | -1,115 | -303 | -114 | 321 |
| Operating Cash Flow | $-4,593 | $-3,310 | $-1,816 | $-6,818 |
| Cash Flows From Investing Activities | ||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $0 |
| Cash Flows From Financing Activities | ||||
| Dividend Paid | N/A | N/A | N/A | 7 |
| Other Financing Activity | 0 | 0 | 0 | 6,232 |
| Financing Cash Flow | $N/A | $N/A | $N/A | $6,239 |
| Beginning Cash Position | 6,552 | 6,552 | 6,552 | 7,131 |
| End Cash Position | 1,959 | 3,242 | 4,736 | 6,552 |
| Net Cash Flow | $-4,593 | $-3,310 | $-1,816 | $-579 |
| Free Cash Flow | ||||
| Operating Cash Flow | -4,593 | -3,310 | -1,816 | -6,818 |
| Free Cash Flow | -4,593 | -3,310 | -1,816 | -6,818 |